AbbVie’s Elahere Receives CHMP Backing for Ovarian Cancer Treatment
In a major development, AbbVie announced on Friday that the European Medicines Agency's Committee for Medicinal Products for Human...
Revolutionize Your Finance News Experience with MorningExpert!
🌟 Custom-Tailored News Just for You: Say goodbye to information overload. Our cutting-edge filtering technology curates your feed to perfection, delivering only the finance news that matches your interests and professional ambitions.
🔔 Flexible Updates, Your Way: How do you like your updates? Choose from instant app notifications, email digests, or captivating video summaries to stay informed on your own terms.
🎥 Engaging Video Summaries: Pressed for time? Let our expert anchors brief you with video summaries, giving you the essence of each news piece in minutes.
🚨 Personalized Alerts: Never miss out on what matters most. Set custom alarms for topics you’re passionate about, and be the first in the know.
📹 Create Your Own Video Content: Dive deeper into the topics that intrigue you with personalized videos. Generated on demand, these videos bring your chosen keywords or interests to life.
MorningExpert is more than a news app; it’s a dedicated companion for anyone passionate about finance. Whether you’re a seasoned professional, an avid enthusiast, or simply eager to stay updated with the finance world, our app ensures you’re always ahead of the curve.
With features designed to make staying informed effortless and enjoyable—such as custom alarms and on-demand video content—navigating the finance landscape has never been simpler or more tailored to your needs.
Transform the way you consume finance news. Download MorningExpert now and step into a world of precision-informed finance knowledge. Your next-level finance journey starts here!
acquisition adjusted earnings AI analysts apple artificial intelligence Bitcoin CEO China demand dividend Donald Trump Dow Jones Industrial Average earnings economy extreme event FactSet Federal Reserve fourth quarter growth guidance hamas inflation interest rates investment investors Israel Microsoft net income net profit Nvidia profit revenue revenue growth S&P 500 sales shareholders shares stock stock market stocks tesla third quarter Trump Wall Street
In a major development, AbbVie announced on Friday that the European Medicines Agency's Committee for Medicinal Products for Human...
AbbVie Inc.'s stock fell 0.5% after the drug company lowered its first-quarter guidance due to the dilutive impact of...
AbbVie, the pharmaceutical company, reported lower revenue in the fourth quarter due to a decline in sales of its...
Consumer sentiment in the US has soared in December, with the University of Michigan consumer sentiment index rising 8.1...
Pharmaceutical company AbbVie has made two major acquisitions in less than a week, transforming its pipeline in cancer and...
In a week of major deals in the health-care industry, AbbVie has agreed to acquire Cerevel Therapeutics for $8.7...
Pharmaceutical company AbbVie is making its second major purchase in two weeks, announcing its acquisition of Cerevel Therapeutics for...
In health-care news, Novo Nordisk shares fell as the surge in obesity-drug makers slowed down. Lawsuits targeting the use...
AbbVie, a pharmaceutical giant, is set to acquire neuroscience-drug maker Cerevel Therapeutics for $8.7 billion. This deal comes just...
Immunogen's cancer therapy, Elahere, has received priority review from the FDA to convert its accelerated approval to full approval....